Clinical Trials Browser

Phase 1 × INDUSTRY × Inosine Monophosphate × Clear all

NCT04230265 2026-01-22

Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04633148 2024-04-23

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Phase 1 Terminated

Prostatic Neoplasms